If you think that they can hit their nominated production costs then they will be a bargain and worth a buy. It's a big if though...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025